• Turning Point Brands recently reported third-quarter earnings that surpassed market expectations, amended its at-the-market equity program by US$200 million, and confirmed a US$0.075 per-share dividend payable on 9 January 2026 following its 19 December 2025 ex-dividend date.
• Amid these updates, a director’s sale of 2,000 shares and a year of only insider sells add an extra layer of context for interpreting the company’s otherwise upbeat operational and capital allocation signals.
• Next, we’ll explore how the strong third-quarter results and increased at-the-market authorization may influence Turning Point Brands’ investment narrative.

We've found 13 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

Turning Point Brands Investment Narrative Recap

To own Turning Point Brands, you have to believe its Modern Oral and premium tobacco brands can keep gaining share despite regulatory, competitive, and social pressure on nicotine. The latest earnings beat, dividend affirmation, and at-the-market expansion all support the near term growth story, while the all time high share price and ongoing insider selling keep valuation and execution risk firmly in focus.

Among the recent announcements, the US$200 million increase in the at-the-market equity program stands out, because it sits alongside strong third quarter results and a rising share price. For investors, that combination can matter for how future growth is funded, how earnings per share evolve, and how much weight to place on current momentum versus the risk that Modern Oral investments and market share gains do not convert into sustained profitability.

Yet amid upbeat earnings and a higher trading range, the heavy reliance on Modern Oral nicotine pouches is something investors should be aware of because...

Turning Point Brands’ narrative projects $745.7 million revenue and $100.8 million earnings by 2028.

Uncover how Turning Point Brands' forecasts yield a $118.75 fair value, a 9% upside to its current price.

Exploring Other Perspectives

Four members of the Simply Wall St Community currently see fair value between US$54.06 and US$158.91, showing very different expectations. Against that backdrop, the dependence on Modern Oral growth and its regulatory and competitive risks could materially influence how Turning Point Brands actually performs over time, so it is worth weighing several of these viewpoints.

Explore 4 other fair value estimates on Turning Point Brands - why the stock might be worth less than half the current price!

Build Your Own Turning Point Brands Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Turning Point Brands research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Turning Point Brands research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Turning Point Brands' overall financial health at a glance.

Seeking Other Investments?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• These 15 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
• The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
• This technology could replace computers: discover 28 stocks that are working to make quantum computing a reality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.